journal article·2025-12

Liposome@IR780 Nanoparticles for Efficient Sonodynamic Therapy to Treat Triple-negative Breast Cancer

Xiaozhu Zhong, Cuiping Guo, Jie Li, Xian Shu, Zhiwen Zeng, Shan Yu, Jiayi Zhou, Ping Wang

Publisher page

Abstract

The hydrophobic sonosensitizer IR780 iodide (IR780) was loaded into liposomes to form Liposome@IR780 nanoparticles (NPs) for triple-negative breast cancer (TNBC) to enhance SDT via low-intensity ultrasound (LIU) irradiation. The NPs were characterized using various physicochemical methods including size distribution, zeta potential, and morphology.In vitroexperiments show that the Liposome@IR780 NPs can generate more reactive oxygen species (ROS) upon LIU irradiation. The apoptosis experiment results further demonstrate that Liposome@IR780 NPs show better apoptosis rate against 4T1 cells. Our results indicate that Liposome@IR780 NPs will provide a promising approach for TNBC upon SDT treatment.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Ultrasound and Hyperthermia Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (34)

Show source-provided references
1. Lu BY, Natarajan E, Raghavendran HRB, et al. Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review[J]. Technol. Cancer Res. T., 2023, 22: 15 330 338 221 145 24610.1177/15330338221145246 ↗
2. Borri F, Granaglia A. Pathology of Triple Negative Breast Cancer[J]. Semin. Cancer Biol., 2021, 72: 136–14510.1016/j.semcancer.2020.06.005 ↗
3. Abad MN, Calabuig-Farinas S, de Mena ML, et al. Update on Systemic Treatment in Early Triple Negative Breast Cancer[J]. Ther. Adv. Med. Oncol., 2021, 13: 1 758 835 920 986 74910.1177/1758835920986749 ↗
4. Riaz F. New Strategies for the Management of Triple-Negative Breast Cancer[J]. Curr. Opin. Obstet. Gyn., 2024, 36(1): 40–4410.1097/GCO.0000000000000927 ↗
5. Ali MA, Aiman W, Shah SS, et al. Efficacy and Safety of Pembrolizumab based Therapies in Triple-Negative Breast Cancer: A Systematic Review of Clinical Trials[J]. Crit. Rev. Oncol. Hemat., 2021, 157: 103 19710.1016/j.critrevonc.2020.103197 ↗
6. Li Y, Zhang HJ, Merkher Y, et al. Recent Advances in Therapeutic Strategies for Triple-Negative Breast Cancer[J]. J. Hematol. Oncol., 2022, 15(1): 12110.1186/s13045-022-01341-0 ↗
7. Dias CJ, Helguero L, Faustino MAF. Current Photoactive Molecules for Targeted Therapy of Triple-Negative Breast Cancer[J]. Molecules, 2021, 26(24): 7 64510.3390/molecules26247654 ↗
8. Ostasnka E, Aebisher D, Bartusik-Aebisher D. The Potential of Photodynamic Therapy in Current Breast Cancer Treatment Methodologies[J]. Biomed. Pharmacother., 2021, 137: 111 30210.1016/j.biopha.2021.111302 ↗
9. Dong CH, Yang P, Wang X, et al. Multifunctional Composite Nanosystems for Precise/Enhanced Sonodynamic Oxidative Tumor Treatment[J]. Bioconjug. Chem. 2022, 33(6): 1 035–1 04810.1021/acs.bioconjchem.1c00478 ↗
10. Hu CT, Hou B, Xie SL. Application of Nanosonosensitizer Materials in Cancer Sono-Dynamic Therapy[J]. RSC Advances, 2022, 12(35): 22 722–22 74710.1039/D2RA03786F ↗
11. Zhao PX, Deng YB, Xiang GY, et al. Nanoparticle-Assisted Sonosensitizers and Their Biomedical Applications[J]. Int. J. Nanomed., 2021, 16: 4 615–4 63010.2147/IJN.S307885 ↗
12. Wu N, Fan CH, Yeh CK. Ultrasound-Activated Nanomaterials for Sonodynamic Cancer Theranostics[J]. Drug Discov. Today, 2022, 27(6): 1 590–1 60310.1016/j.drudis.2022.02.025 ↗
13. Uddin SMZ, Komatsu DE, Motyka T, et al. Low-Intensity Continuous Ultrasound Therapies-A Systematic Review of Current State-of-The-Art and Future Perspectives[J]. J. Clin. Med., 2021, 10(12): 2 69810.3390/jcm10122698 ↗
14. Wan GY, Liu Y, Chen BW, et al. Recent Advances of Sonodynamic Therapy in Cancer Treatment[J]. Cancer Biol. Med., 2016, 13(3): 325–33810.20892/j.issn.2095-3941.2016.0068 ↗
15. Ji XY, Duan H, Wang S, et al. Low-Intensity Pulsed Ultrasound in Obstetrics and Gynecology: Advances in Clinical Application and Research Progress[J]. Front. Endocrinol., 2023, 14: 1 233 18710.3389/fendo.2023.1233187 ↗
16. Panzone J, Byler T, Bratslavsky G, et al. Applications of Focused Ultrasound in the Treatment of Genitourinary Cancers[J]. Cancers, 2022, 14(6): 1 53610.3390/cancers14061536 ↗
17. Lin BW, Du H, Fan JJ, et al. Radioimmunotherapy Combined with Low-Intensity Ultrasound and Microbubbles: A Potential Novel Strategy for Treatment of Solid Tumors[J]. Front. Oncol., 2021, 11: 750 74110.3389/fonc.2021.750741 ↗
18. Zhou HY, Chen Y, Li P, He XX, et al. Sonodynamic Therapy for Breast Cancer: A Literature Review[J]. Open Chem., 2022, 20(1): 1 045–1 05610.1515/chem-2022-0186 ↗
19. Li L, Lin HR, Li DF, et al. Ultrasound Activated Nanosensitizers for Sonodynamic Therapy and Theranostics[J]. Biomed. Mater., 2021, 16(2): 022 00810.1088/1748-605X/abd382 ↗
20. Xu MM, Zhou LQ, Zheng L, et al. Sonodynamic Therapy-Derived Multimodal Synergistic Cancer therapy[J]. Cancer Lett., 2021, 497: 229–24210.1016/j.canlet.2020.10.037 ↗
21. Li JL, Yue ZY, Tang ML, et al. Strategies to Reverse Hypoxic Tumor Microenvironment for Enhanced Sonodynamic Therapy[J]. Adv. Healthc. Mater., 2024, 13 (1): 2 302 02810.1002/adhm.202302028 ↗
22. Hu HY, Zhao JH, Ma KZ, et al. Sonodynamic Therapy Combined with Phototherapy: Novel Synergistic Strategy with Superior Efficacy for Antitumor and Antiinfection Therapy[J]. J. Control. Release, 2023, 359: 188–20510.1016/j.jconrel.2023.05.041 ↗
23. Capistrano G, Sousa AA, Silva RA, et al. IR-780-Albumin-Based Nanocarriers Promote Tumor Regression not only from Phototherapy but Also by a Nonirradiation Mechanism[J]. ACS Biomater.-Sci. Eng., 2020, 6(8): 4 523–4 53810.1021/acsbiomaterials.0c00164 ↗
24. Ghosh A, Rajdev B, Parihar N, et al. Bio-Nanoconjugates of Lithocholic Acid/IR 780 for ROS-Mediated Apoptosis and Optoacoustic Imaging Applications in Breast Cancer[J]. Colloid. Surface. B, 2023, 221: 113 02310.1016/j.colsurfb.2022.113023 ↗
25. Wang L, Niu CC. IR780-Based Nanomaterials for Cancer Imaging and Therapy[J]. J. Mater. Chem. B, 2021, 9: 4 079–4 09710.1039/D1TB00407G ↗
26. Zhang L, Wang D, Yang K, et al. Mitochondria-Targeted Artificial “Nano-RBCs” for Amplified Synergistic Cancer Phototherapy by a Single NIR Irradiation[J]. Adv. Sci., 2018, 5: 1 800 04910.1002/advs.201800049 ↗
27. Li YK, Zhou QF, Deng ZT, et al. IR-780 Dye As A Sonosensitizer for Sonodynamic Therapy of Breast Tumor[J]. Sci. Rep., 2016, 6: 1–1010.1038/s41598-016-0001-8 ↗
28. Shen CX, Yue XF, Dai LY, et al. Hyperbaric Oxygen Enhanced the Chemotherapy of Mitochondrial Targeting Molecule IR-780 in Bladder Cancer[J]. J. Cancer Res. Clin., 2023, 149(2): 683–69910.1007/s00432-022-04385-4 ↗
29. Bukhari SI, Imam SS, Ahmad MZ, et al. Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges[J]. Pharmaceuticals, 2021, 13: 84010.3390/pharmaceutics13060840 ↗
30. Li YB, Yang J, Sun XL. Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy[J]. Front. Chem., 2021, 9: 650 58710.3389/fchem.2021.650587 ↗
31. Zhang LZ, Zhu CY, Huang RT, et al. Mechanisms of Reactive Oxygen Species Generated by Inorganic Nanomaterials for Cancer Therapeutics[J]. Front. Chem., 2021, 9: 630 96910.3389/fchem.2021.630969 ↗
32. Mungur R, Zheng JS, Wang B, et al. Low-Intensity Focused Ultrasound Technique in Glioblastoma Multiforme Treatment[J]. Front. Oncol., 2022, 12: 903 05910.3389/fonc.2022.903059 ↗
33. Snehota M, Vachutka J, Haar ter G, et al. Therapeutic Ultrasound Experiments in Vitro: Review of Factors Influencing Outcomes and Reproducibility[J]. Ultrasonics, 2020, 107: 106 16710.1016/j.ultras.2020.106167 ↗
34. Hu CT, Hou B, Xie SL. Application of Nanosonosensitizer Materials in Cancer Sono-Dynamic Therapy[J]. RSC Advances, 2022, 12: 22 722–22 74710.1039/D2RA03786F ↗